Home > News > Labopharm reports results for third quarter fiscal 2004
October 28th, 2004
Labopharm reports results for third quarter fiscal 2004
Abstract:
Labopharm Inc. (TSX: DDS) today reported its results for the third quarter of fiscal 2004 ended
September 30, 2004. Net loss for the third quarter of fiscal 2004 was $5.9 million, or $0.14
per share, compared with $7.9 million, or $0.22 per share, for the third quarter of fiscal 2003.
Source:
prnewswire
Bookmark:
Labopharm
Announcements
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013
Financial Reports
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013